Latest filing published 23 Jun 2025 for Mimedx Group, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Todd Newton span 2 companies, the busiest being Apollo Endosurgery, Inc. and Mimedx Group, Inc. Over a trading history stretching from 29 December 2016 to 23 June 2025, the count stands at 21 filings.
No open-market sale appears; the market trades are 6 purchases worth €1.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 12 share grants.
The median purchase comes to €42k. On 5 out of 6 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 23 June 2025 came the latest disclosure, a share grant in Mimedx Group, Inc. The clock since the last published purchase (14 May 2019) now reads 2,719 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations